EKARD Institute for Cancer Diagnosis Research
Director: Prof. Yardena Samuels
The EKARD Institute for Cancer Diagnosis Research, part of The Moross Integrated Cancer Center (MICC), provides a supportive framework for leading researchers working on novel ways to achieve early detection of cancer, which may help clinicians provide more accurate diagnoses and identify specific molecular signatures. Early detection and diagnosis of cancer can greatly improve the medical community's ability to control the outcome of therapy, offer the most effective treatment, and avoid useless and often harsh methods of combating the disease.
Moross Integrated Cancer Center (MICC)
Director: Prof. Moshe Oren
The Moross Integrated Cancer Center (MICC) works to unravel the complexity of cancer by harnessing the power of basic research to facilitate translation into the clinical arena in the quest for cancer prevention, early diagnosis and, ultimately, a cure. The overarching goal of the MICC is to move toward personalized cancer medicine, facilitating translational research by enabling the flow of insights from the lab and feedback from patient treatment and samples. The MICC includes six components: the Swiss Society Institute for Cancer Prevention Research, the Ekard Institute for Cancer Diagnosis Research, the Dwek Institute for Cancer Therapy Research, The de Picciotto-Lesser Cancer Cell Observatory in Memory of Wolfgang and Ruth Lesser, the Weizmann-Brazil Tumor Bank, and the Kleinman Cancer Cell Sorting Facility.